GGM Financials’s Pfizer PFE Stock Holding History

GGM Financials’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21K	Hold	870	–	–	0.01%	202
2026 Q1	$24.4K	Hold	870	–	–	0.01%	170
2025 Q4	$21.7K	Hold	870	–	–	0.01%	161
2025 Q3	$22.2K	Buy	+870	New	+$21.5K	0.01%	153

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GGM Financials's PFE Position: Q2 2026 in Review

GGM Financials held its Pfizer (PFE) position steady in Q2 2026 at 870 shares worth $21K. The position accounts for 0.01% of the portfolio, ranked #202.

GGM Financials first reported a position in PFE in Q3 2025 and has held it in 4 quarters since. The position peaked at $24.4K in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

GGM Financials held 870 shares of Pfizer worth $21K as of Q2 2026.
GGM Financials left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.01% of GGM Financials's portfolio in Q2 2026, its #202 holding.
GGM Financials first reported a position in Pfizer in Q3 2025 and has held it in 4 quarters since.
GGM Financials's Pfizer position peaked at $24.4K in Q1 2026.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on GGM Financials's 13F filing for Q2 2026, filed 23 Jul 2026.